Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Many farmers undecided about BTV-3 vaccination, survey finds
There have been over 160 cases of BTV-3 in the current vector period.
Ruminant Health & Welfare publishes early findings from farmer survey.

There is hesitancy about bluetongue virus serotype 3 (BTV-3) vaccinations among farmers, initial findings from a survey looking at the impact of the outbreak on farmers suggest.

Over half of the farmers who responded said they remain undecided about vaccination, though a significant number, particularly sheep farmers, said that they plan to vaccinate before the next summer season.

The survey, which is being conducted by Ruminant Health & Welfare in collaboration with Flock Health Limited, the Agriculture and Horticulture Development Board (AHDB), and the University of Nottingham, has also revealed the impact that the outbreak is having on farmers.

Some have reported that it has become more difficult to sell their livestock. Another, who had experienced mortality on their farm due to bluetongue, described the experience as “horrible; physically, financially, mentally and emotionally.”

Alongside the survey, the Animal and Plant Health Agency is studying the impact of the virus on premises where it has been confirmed. Signs seen in infected animals include lameness, swollen faces, nose and mouth ulcers, drooling, breathing difficulties, nasal discharge, and mortality.

Fiona Lovatt, of Flock Health Limited, said: “We know that in Germany, the research shows a marked difference in outcomes between vaccinated and unvaccinated herds and flocks.

“Findings indicate that unvaccinated sheep flocks have experienced mortality rates as high as 30 per cent, whereas vaccinated flocks show significantly lower mortality, with some reporting only 1-2 per cent losses.

“We want to learn from this data and build a UK base of evidence that we can trust going forwards.”

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office. Suspected cases in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.

Image © Shutterstock

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.